Press Releases

 Filter by Provider

TIC Solutions, Inc. (NYSE: TIC) (the “Company” or “TIC Solutions”), a leading provider of tech-enabled Testing, Inspection, Certification, and Compliance (TICC), engineering, and geospatial services, announced today that it intends to release its financial results for the fourth quarter and full year 2025 before the market opens on Thursday, March 12, 2026.

Fourth Quarter Net Revenues Increased by 32.9% Year-over-Year to RMB12.8 Billion

Palmer Square Capital BDC Inc. (NYSE: PSBD) (“PSBD” or the “Company”), an externally managed business development company, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

Continuous AI penetration testing that validates exploitability and closes the remediation loop

Planning Tools for Orderly Succession and Long‑Term Business Continuity

Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced results for the quarter ended December 31, 2025 and its financial outlook for 2026.

MONTREAL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis” or “the Company”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, announces today the successful results of a primary testing campaign with a leading battery recycler.

– Company on track to report ELEVATE-44-201 data from Cohort 1 in Q2 2026 and Cohort 2 by year-end 2026 –

Cotality, a leading global property information, analytics, and data-enabled solutions provider, today announced the appointment of Wayne Peacock as an independent member of its board, effective February 18, 2026.

BOSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a live conference call and audio webcast on Thursday, March 5, 2026, at 4:30 p.m. ET to report financial results for the fourth quarter and full year ended December 31, 2025, and to provide a business update.

Topline 6-month pivotal data expected in early Q4 2026 with potential FDA marketing application submission expected in late Q4 2026

Seasonal Innovation Strengthens Good Supply’s Position in Vape and Pre-roll Formats, Supporting Continued Retail Momentum and Consumer Demand

Cemsidomide Advancing into Later-stage Development with Potential for Accelerated Approval; First Patient Dosed in the Phase 2 MOMENTUM Trial for Multiple Myeloma in the Fourth Line or Later

-Expands Advanced Packaging Platform Across Wafer-Level and Panel-Level Applications in Key Global Markets-

Completed enrollment of Cohort C in the Phase 1 ALLOHA™ trial; patients to be treated with commercial-ready manufacturing process

MORRISVILLE, N.C., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today that it will report its full year 2025 financial results on Thursday, March 5, 2026. The company will host a live webcast at 8:30 a.m. Eastern Time to discuss its financial results and provide a corporate update.

GOLETA, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum, today announced that its CEO Jonathan Klamkin, Ph.D., and CFO Christopher Stewart will participate in the 38th Annual ROTH Conference on March 23, 2026 in Dana Point, California at the Ritz-Carlton Laguna Niguel. The management team will participate in one-on-ones and small group meetings with analysts and investors.

-- Fourth quarter 2025 net product revenue from global sales of IMCIVREE® (setmelanotide) of $57.3 million --

RICHMOND, Va., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today reported its financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update.

BEDFORD, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today reported financial results for its fourth quarter and full year ended December 31, 2025.

Collaboration will deliver collective training designed and delivered to meet today’s modern battlefield and Canada’s defence modernization priorities

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or the “Company”), a clinical‑stage biotechnology company on a mission to transform patient outcomes by developing rapid‑acting, durable and convenient treatments for mental health conditions, today announced topline results from its exploratory, double‑blind, placebo‑controlled, first-in-patient Phase 2a study (NCT06693609) evaluating EMP‑01 (oral R‑MDMA) in adults with Social Anxiety Disorder (SAD). The study met its primary safety objective and generated encouraging secondary and exploratory efficacy signals in a highly severe, difficult‑to‑treat population.

—Delivering Record Revenue and EPS—

-Represents ACM’s First Delivery to Singapore-based Facility-

FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced packaging applications, today reported financial results for its fourth quarter and fiscal year ended December 31, 2025.

EDINBURG, Va., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (“Shentel”) (Nasdaq: SHEN) announced fourth quarter and full year 2025 financial and operating results.

FLORHAM PARK, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided 2026 financial guidance.

SANTA MONICA, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) (the “Company” or “Macerich”) today announced that Jack Hsieh, President and Chief Executive Officer, and Dan Swanstrom, Senior Executive Vice President and Chief Financial Officer, will participate in a round table presentation at Citi’s 2026 Global Property CEO Conference on Monday, March 2, 2026, at 2:55 PM Eastern Time.

SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers Squibb (NYSE: BMY) today announced that SystImmune’s parent company, Sichuan Biokin Pharmaceutical Co., Ltd. (Biokin), reported positive topline results from a pre-specified interim analysis of a Phase III study (BL-B01D1-307) evaluating izalontamab brengitecan (iza-bren), an EGFR×HER3 bispecific antibody-drug conjugate (ADC), in patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) whose disease progressed following prior taxane therapy.

Magnachip Semiconductor Corporation (NYSE: MX, “Magnachip”) today announced the launch of its new 7th-generation 24V MXT LV MOSFET1 specifically designed for battery protection circuits in next-generation tri-fold smartphones, strengthening its presence in the premium foldable smartphone market. The product is now in mass production and is currently being supplied to a major global smartphone manufacturer, having demonstrated proven performance and reliability.

Based on verified 5-star reviews and market popularity in the property management software category, the awards reflect RentRedi’s ongoing collaboration with independent landlords nationwide

The nature of cryptocurrency markets is volatile, and the rate of price fluctuations may introduce a high degree of both profit and risk. Volatility refers to the reaction to sudden macroeconomic news, fluctuations in investor sentiment, or liquidity shocks that increase market uncertainty. The slightest inconvenience in the order entry or cosmetic liquidity may lead […]

The Wyss Center for Bio and Neuroengineering Geneva announced today the successful closing of the Seed financing round of Clee Medical SA, a Swiss neurotechnology spin-off developing ultra-high-resolution real-time intraoperative imaging for brain surgery. The round was led by High-Tech Gründerfonds (HTGF), with participation from Zürcher Kantonalbank (ZKB), Kickfund, FONGIT, and Venture Kick joining existing investors Wyss Center Geneva.

As the digital asset market continues to evolve at a rapid pace, crypto trading is increasingly about more than charts, execution speed, and technical strategies. Market volatility, uncertainty, and past losses often place emotional and psychological pressure on traders — particularly newcomers navigating crypto space for the first time.

Warby Parker Inc. (NYSE: WRBY) (“Warby Parker” or the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the fourth quarter and full year ended December 31, 2025.

Krispy Kreme, Inc. (NASDAQ: DNUT) (“Krispy Kreme”, “KKI”, or the “Company”) today reported financial results for the fourth quarter and full year ended December 28, 2025.

International Seaways, Inc. (NYSE: INSW) (the “Company,” “Seaways,” or “INSW”), one of the largest tanker companies worldwide providing energy transportation services for crude oil and petroleum products, today reported results for the fourth quarter and full year 2025.

Kolibri Global Energy Inc. (the “Company” or “Kolibri”) (TSX: KEI, NASDAQ: KGEI) is announcing that it has released its first Sustainability Report, which is available on the Company’s website at www.kolibrienergy.com under the “Investor” section.

Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 31, 2026, to shareholders of record at the close of business on March 6, 2026. Additional information about Teleflex can be obtained from the company’s website at teleflex.com.

Atlantic Union Bankshares Corporation (“the Company”) today announced that it will present at the Raymond James 47th Annual Institutional Investors Conference on Tuesday, March 3, 2026.

Casein Market Report highlights strong growth driven by rising demand for functional proteins in sports, medical nutrition, and fortified food applications globally.

 

According to industry analysis, increasing cases of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, celiac disease, and other chronic autoimmune conditions are driving testing volumes worldwide.

Revenue of $678.8 million and Direct-to-Consumer (“DTC”) Revenue of $250.1 millionDTC Revenue Increased 19.5% Sequentially and 43.2% Year-Over-Year Net Loss of $(309.3) million, Adjusted Net Income of $89.0 million, and Adjusted EBITDA of $201.4 million

A 2025 survey by the Japan Frozen Food Association shows a slight rise in frozen food usage. The main factors were rising prices for fresh vegetables and convenience. Mochi is highly sticky, so be careful to avoid choking accidents. (Photo via MERXWIRE) TOKYO, JAPAN (MERXWIRE) - A 2025 survey by the Japan Frozen Food Association...

EDISON, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”), America’s leading innovator in designing, manufacturing, and providing zinc-based long duration energy storage (LDES) systems sourced and manufactured in the United States, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

The Middleby Corporation (NASDAQ: MIDD), a global leader in the foodservice industry, today announced that Mark Salman, currently President of the Middleby Food Processing Group (FPG), will serve as Chief Executive Officer of the Food Processing business when it becomes an independent public company in the second quarter of 2026. It was also announced that Mark Bowie will serve as the Chief Operating Officer of the Food Processing business upon the completion of the spin-off transaction.

TORONTO, ONTARIO / ACCESS Newswire / February 26, 2026 / CCL Industries Inc. ("the Company" or "CCL") (TSX:CCL.A)(TSX:CCL.B), a world leader in specialty label, security and packaging solutions for global corporations, government institutions, small businesses and consumers, announced today that it has entered into an automatic securities purchase plan ("ASPP") with a designated broker in order to facilitate purchases of the Company's Class B non-voting shares under its previously announced normal course issuer bid (the "Bid"). The ASPP will be implemented effective March 2, 2026.

Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the year ended December 31, 2025.